104 related articles for article (PubMed ID: 17446269)
1. Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method.
Martin SS; Holleran BJ; Escher E; Guillemette G; Leduc R
Mol Pharmacol; 2007 Jul; 72(1):182-90. PubMed ID: 17446269
[TBL] [Abstract][Full Text] [Related]
2. Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.
Holleran BJ; Domazet I; Beaulieu ME; Yan LP; Guillemette G; Lavigne P; Escher E; Leduc R
Biochem Pharmacol; 2009 Apr; 77(8):1374-82. PubMed ID: 19426676
[TBL] [Abstract][Full Text] [Related]
3. The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.
Domazet I; Holleran BJ; Martin SS; Lavigne P; Leduc R; Escher E; Guillemette G
J Biol Chem; 2009 May; 284(18):11922-9. PubMed ID: 19276075
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis.
Martin SS; Boucard AA; Clément M; Escher E; Leduc R; Guillemette G
J Biol Chem; 2004 Dec; 279(49):51415-23. PubMed ID: 15452107
[TBL] [Abstract][Full Text] [Related]
5. The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation.
Domazet I; Martin SS; Holleran BJ; Morin ME; Lacasse P; Lavigne P; Escher E; Leduc R; Guillemette G
J Biol Chem; 2009 Nov; 284(46):31953-61. PubMed ID: 19773549
[TBL] [Abstract][Full Text] [Related]
6. Analysis by substituted cysteine scanning mutagenesis of the fourth transmembrane domain of the CXCR4 receptor in its inactive and active state.
Boulais PE; Escher E; Leduc R
Biochem Pharmacol; 2013 Feb; 85(4):541-50. PubMed ID: 23219524
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket.
Boucard AA; Roy M; Beaulieu ME; Lavigne P; Escher E; Guillemette G; Leduc R
J Biol Chem; 2003 Sep; 278(38):36628-36. PubMed ID: 12842881
[TBL] [Abstract][Full Text] [Related]
8. Analysis of transmembrane domains 1 and 4 of the human angiotensin II AT1 receptor by cysteine-scanning mutagenesis.
Yan L; Holleran BJ; Lavigne P; Escher E; Guillemette G; Leduc R
J Biol Chem; 2010 Jan; 285(4):2284-93. PubMed ID: 19940150
[TBL] [Abstract][Full Text] [Related]
9. Identification of transmembrane domain 3, 4 & 5 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor.
Sainsily X; Cabana J; Boulais PE; Holleran BJ; Escher E; Lavigne P; Leduc R
Biochem Pharmacol; 2013 Dec; 86(11):1584-93. PubMed ID: 24084430
[TBL] [Abstract][Full Text] [Related]
10. Identification of transmembrane domain 1 & 2 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor.
Sainsily X; Cabana J; Holleran BJ; Escher E; Lavigne P; Leduc R
Biochem Pharmacol; 2014 Nov; 92(2):280-8. PubMed ID: 25175740
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
[TBL] [Abstract][Full Text] [Related]
12. MTSEA prevents ligand binding to the human melanocortin-4 receptor by modification of cysteine 130 in transmembrane helix 3.
Cox A; Donnelly D; Kaur M; Cheetham SC; Cockcroft VB; Findlay JB
FEBS Lett; 2005 Jan; 579(1):285-91. PubMed ID: 15620728
[TBL] [Abstract][Full Text] [Related]
13. Agonist-driven conformational changes in the inner beta-sheet of alpha7 nicotinic receptors.
McLaughlin JT; Fu J; Rosenberg RL
Mol Pharmacol; 2007 May; 71(5):1312-8. PubMed ID: 17325129
[TBL] [Abstract][Full Text] [Related]
14. Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis.
Sucic S; Bryan-Lluka LJ
J Neurochem; 2005 Sep; 94(6):1620-30. PubMed ID: 16092934
[TBL] [Abstract][Full Text] [Related]
15. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice.
Javitch JA; Ballesteros JA; Weinstein H; Chen J
Biochemistry; 1998 Jan; 37(4):998-1006. PubMed ID: 9454590
[TBL] [Abstract][Full Text] [Related]
16. Temperature-dependent variations of ligand-receptor contact points in hAT(1).
Arsenault J; Renaud MP; Clément M; Fillion D; Guillemette G; Leduc R; Lavigne P; Escher E
J Pept Sci; 2007 Sep; 13(9):575-80. PubMed ID: 17600857
[TBL] [Abstract][Full Text] [Related]
17. Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice.
Fu D; Ballesteros JA; Weinstein H; Chen J; Javitch JA
Biochemistry; 1996 Sep; 35(35):11278-85. PubMed ID: 8784181
[TBL] [Abstract][Full Text] [Related]
18. Participation of transmembrane proline 82 in angiotensin II AT1 receptor signal transduction.
Reis RI; Santos EL; Pesquero JB; Oliveira L; Schanstra JP; Bascands JL; Pecher C; Paiva AC; Costa-Neto CM
Regul Pept; 2007 Apr; 140(1-2):32-6. PubMed ID: 17239455
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants of the closed KCa3.1 channel pore in relation to channel gating: results from a substituted cysteine accessibility analysis.
Klein H; Garneau L; Banderali U; Simoes M; Parent L; Sauvé R
J Gen Physiol; 2007 Apr; 129(4):299-315. PubMed ID: 17353352
[TBL] [Abstract][Full Text] [Related]
20. A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding.
Sen N; Shi L; Beuming T; Weinstein H; Javitch JA
Neuropharmacology; 2005 Nov; 49(6):780-90. PubMed ID: 16216288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
